Strategy, generation and planning

A robust, comprehensive evidence base is crucial in demonstrating the effectiveness and, ultimately, the value of your product to payers and other key stakeholders. Our team of market access experts and evidence-based scientists will support you in understanding the evidence needed to achieve success, and in the planning, execution and implementation of evidence generation activities to support your access strategy.

Evidence generation strategy

Generating the right evidence base to demonstrate the effectiveness and value of your product is at the heart of achieving commercial success. Our multidisciplinary team, with expertise across the fields of clinical research, health economics, statistical analysis, and market access and pricing, can support you in developing a robust, actionable evidence generation strategy to maximise the potential for success. We can help you develop a roadmap of activities, both strategic and tactical, that will define the steps required to develop evidence that will resonate with both clinicians and payers alike.

Systematic literature review

Before engaging with payers and reimbursement bodies, it is critical to have a full picture of the evidence supporting your product’s proposition. Systematic literature review is the gold standard method for identifying and synthesising published evidence. Moreover, it has become an essential element of “launch preparedness”, as many health technology assessment bodies around the world now require evidence to be identified via systematic methods.

At Mtech Access, we understand the challenge of developing and maintaining an evidence platform for healthcare interventions. Our experienced in-house team use the latest techniques and methods to develop research questions and protocols, as well as process, and summarise the evidence found.


Meta-analysis has become a key technique in evaluating comparative evidence and informing payer decisions worldwide, and is increasingly a core evidence pillar supporting product value propositions. At Mtech Access, we are leading the way in indirect statistical methods, regularly publishing and presenting our work at international conferences. Our in-house literature review analysts and medical statisticians work side-by-side to enable a seamless transition between the systematic review and the meta-analysis feasibility assessment and full statistical analysis. Importantly, our statisticians conduct the feasibility analysis, ensuring that the right data is evaluated and a sound conclusion is reached first time.

Health economic evaluation

Evaluating the economic case for a product is at the core of many reimbursement and health technology assessment processes worldwide; therefore, developing a robust and appropriate economic argument is crucial to commercial success.

Our senior health economists have over 13 years of technical and commercial modelling experience, and lecture health economic modelling principles and techniques at City, University of London. All Masters degree trained, our modelling team use the latest techniques and methods to ensure that our models are robust and fit-for-purpose in today’s challenging environment.

Name / Name / Name

Data analytics

Healthcare data is complex and increasingly ubiquitous – and this presents a challenge for stakeholders needing ready-to-go insights to inform their prescribing and reimbursement decisions. Our in-house data analytics team are experienced and skilled at evaluating patient-level and real world data, and transforming them into actionable insights.

Early scientific advice strategy and support

Engaging with regulators and payers at an early stage of product development is becoming more and more important in ensuring the evidence base you develop is suitable to meet the requirements of different market access stakeholders. Our multidisciplinary team can support you through these engagements, whether via official processes with payer bodies such as NICE and G-BA, or through direct research with stakeholders via methods such as one-to-one interviews, advisory boards or workshops.

Name / Name / Name